GlassScriptPhysician profile
Karen Taft
NPI 1528070596
$693.61
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.15 · 2022: $161 · 2023: $260 · 2024: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $301.53 | 2021-2024 | Krystexxa, Evenity, Prolia |
| Ferring Pharmaceuticals INC. | $164.61 | 2022-2024 | Euflexxa |
| Smith+Nephew, INC. | $50.00 | 2023 | Redapt, Or3o Dual Mobility, Tandem |
| Medacta USA, INC. | $36.54 | 2023 | Primary Shoulder |
| Fidia Pharma USA INC. | $32.70 | 2023 | Hymovis, Triluron |
| Bioventus LLC | $30.89 | 2022-2023 | Durolane |
| Endo Pharmaceuticals INC. | $17.41 | 2023 | Xiaflex |
| Kowa Pharmaceuticals America, INC. | $16.89 | 2023 | Seglentis |
| Pacira Pharmaceuticals Incorporated | $15.88 | 2023 | Exparel, Iovera, Zilretta |
| Vertex Pharmaceuticals Incorporated | $14.35 | 2024 | |
| Convatec INC. | $12.81 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Taft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.